Beam Therapeutics Inc.BEAMNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank88
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-29.92M
↑ 80% vs avg
Percentile
P88
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-153.14M
Historical baseline
PeriodValueYoY Change
2025$-29.92M+92.4%
2024$-393.64M-167.9%
2023$-146.95M+54.7%
2022$-324.33M-41.0%
2021$-230.06M-79.7%
2020$-128.03M-78.7%
2019$-71.65M-58.9%
2018$-45.09M-425.3%
2017$-8.58M-